US HB1839 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 28 2023 - 25% progression
Action: 2023-04-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 28 2023 - 25% progression
Action: 2023-04-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To prohibit certain uses of xylazine, and for other purposes.
Title
Combating Illicit Xylazine Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-04-07 | House | Referred to the Subcommittee on Health. |
| 2023-03-28 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2023-03-28 | House | Introduced in House |
Same As/Similar To
SB993 (Same As) 2024-01-11 - Committee on Banking, Housing, and Urban Affairs. Hearings held.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/1839/all-info |
| Text | https://www.congress.gov/118/bills/hr1839/BILLS-118hr1839ih.pdf |
